H-FGRF-OH

Ref. 3D-PP49918

Información del producto

• Nombre: H-FGRF-OH

Descripción

Peptide H-FGRF-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-FGRF-OH include the following: Clinical manifestations and spermatogenesis outcomes in Chinese patients with congenital hypogonadotropic hypogonadism caused by inherited or de novo FGFR1 YF Yang, HL Ma, X Wang, M Nie, JF Mao - Asian Journal of , 2024 - journals.lww.comhttps://journals.lww.com/ajandrology/fulltext/9900/clinical_manifestations_and_spermatogenesis.151.aspx Myelin basic protein (MBP) and MBP peptides are mitogens for cultured astrocytes SA South, GE Deibler, SF Tzeng, A Badache - Glia, 2000 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/(SICI)1098-1136(20000101)29:1%3C81::AID-GLIA8%3E3.0.CO;2-O Natural Sourced inhibitors of EGFR, PDGFR, FGFR and VEGFRMediated signaling pathways as potential anticancer agents S Nandi, R Dey , A Samadder , A Saxena - Current Medicinal , 2022 - ingentaconnect.comhttps://www.ingentaconnect.com/content/ben/cmc/2022/00000029/00000002/art00005 Membrane-derived inhibitory factors P Datta - Tissue Growth Factors, 1981 - Springerhttps://link.springer.com/chapter/10.1007/978-3-642-67986-5_10 Reciprocal priming between receptor tyrosine kinases at recycling endosomes orchestrates cellular signalling outputs MP Smith , HR Ferguson, J Ferguson, E Zindy - The EMBO , 2021 - embopress.orghttps://www.embopress.org/doi/abs/10.15252/embj.2020107182 Density-dependent regulation of cell growth: an example of a cell-cell recognition phenomenon MA Lieberman, L Glaser - The Journal of membrane biology, 1981 - Springerhttps://link.springer.com/article/10.1007/BF01969440 FGFR as potential target in the treatment of squamous non small cell lung cancer M Tiseo, F Gelsomino, R Alfieri , A Cavazzoni - Cancer treatment , 2015 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0305737215000808 Rational discovery of small molecule inhibitor targeting invasion and tumor growth KS Kumar, C Brunner, M Schuster, L Kopp, A Gries - 2022 - researchsquare.comhttps://www.researchsquare.com/article/rs-1359115/latest Discovery of a small molecule ligand of FRS2 that inhibits invasion and tumor growth K Santhana Kumar, C Brunner, M Schuster, LL Kopp - Cellular Oncology, 2023 - Springerhttps://link.springer.com/article/10.1007/s13402-022-00753-x?trk=public_profile_project-button A STUDY OF GROWTH REGULATION IN 3T3 FIBROBLASTS (GLUCOSAMINIDASE, TUNICAMYCIN, GROWTH INHIBITORS) JM Hilfinger - 1984 - search.proquest.comhttps://search.proquest.com/openview/aa5eea212cd6adfbd1a5c7e0901566e0/1?pq-origsite=gscholar&cbl=18750&diss=y Novel"ruthenium cyclopentadienyl"-peptide conjugate complexes against human FGFR (+) breast cancer JF Machado , M Machuqueiro , F Marques - Dalton , 2020 - pubs.rsc.orghttps://pubs.rsc.org/en/content/articlehtml/2020/dt/d0dt00955e Biasing receptor tyrosine kinase signaling pathways J Watson, BJ Arey, A Alt - Biased Signaling in Physiology, Pharmacology , 2014 - Elsevierhttps://www.sciencedirect.com/science/article/pii/B9780124114609000057 Tissue microarray-based studies of patients with lymph node negative breast carcinoma show that met expression is associated with worse outcome but is not I Tolgay Ocal, M Dolled-Filhart - Journal of the , 2003 - Wiley Online Libraryhttps://acsjournals.onlinelibrary.wiley.com/doi/abs/10.1002/cncr.11335 The substrate as a skeleton: ground reaction forces from a soft-bodied legged animal HT Lin , BA Trimmer - Journal of Experimental Biology, 2010 - journals.biologists.comhttps://journals.biologists.com/jeb/article-abstract/213/7/1133/10142 Antiangiogenic heparin-derived heparan sulfate mimics B Casu, A Naggi - Pure and applied chemistry, 2003 - degruyter.comhttps://www.degruyter.com/document/doi/10.1351/pac200375020157/html Molecular docking study on the potency of glycosaminoglycans (GaGs) as co-activators of fibroblasts proliferation and differentiation A Neamtu , M Neamtu , T Petreus - of Experimental and , 2010 - researchgate.nethttps://www.researchgate.net/profile/Andrei-Neamtu/publication/267783007_Molecular_docking_study_on_the_potency_of_glycosaminoglycans_GaGs_as_co-activators_of_fibroblasts_proliferation_and_differentiation/links/54c4b2910cf256ed5a955fe0/Molecular-docking-study-on-the-potency-of-glycosaminoglycans-GaGs-as-co-activators-of-fibroblasts-proliferation-and-differentiation.pdf Association of syndecan-1 with angiogenesis-related markers, extracellular matrix components, and clinicopathological features in colorectal carcinoma A Mitselou , U Skoufi, KE Tsimogiannis - Anticancer , 2012 - ar.iiarjournals.orghttps://ar.iiarjournals.org/content/32/9/3977.short

• Marca: Biosynth

Propiedades químicas

• Peso molecular: 525.61 g/mol